BIOMAT Database Logo BIOMAT Database Logo

Empiric antibiotic therapy in the neutropenic patient. 1988

M Boogaerts

UI MeSH Term Description Entries
D009503 Neutropenia A decrease in the number of NEUTROPHILS found in the blood. Neutropenias
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005335 Fever of Unknown Origin Fever in which the etiology cannot be ascertained. Unknown Origin Fever,Unknown Origin Fevers
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000380 Agranulocytosis A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS). Granulocytopenia,Agranulocytoses,Granulocytopenias
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

M Boogaerts
Overview of empiric antibiotic therapy for the febrile neutropenic patient.
January 1985, Reviews of infectious diseases,
M Boogaerts
Empiric antifungal therapy for the neutropenic patient.
March 2001, Oncology (Williston Park, N.Y.),
M Boogaerts
Antibiotic combinations for the empiric treatment of the febrile neutropenic patient.
January 1983, Schweizerische medizinische Wochenschrift. Supplementum,
M Boogaerts
Empiric therapy for the febrile neutropenic patient. Design bias.
September 1998, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer,
M Boogaerts
Cost comparison of seven antibiotic combinations as empiric therapy in a simulated febrile neutropenic patient.
November 1985, American journal of hospital pharmacy,
M Boogaerts
Simplification of empiric therapy for the febrile, neutropenic oncology patient.
January 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
M Boogaerts
The spectrum of bacterial infections in febrile neutropenic patients: effect on empiric antibiotic therapy.
December 1998, JPMA. The Journal of the Pakistan Medical Association,
M Boogaerts
Therapy of choice for the empiric treatment of the febrile neutropenic patient.
October 1986, Drug intelligence & clinical pharmacy,
M Boogaerts
Empiric antifungal therapy in neutropenic cancer patients.
January 2006, Current infectious disease reports,
M Boogaerts
Empiric antibiotic therapy.
May 1978, Cancer treatment reports,
Copied contents to your clipboard!